Deactivation of left ventricular assist device (LVAD) after recovery of cardiac function: A case report.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Aug 2021
Historique:
revised: 05 03 2021
received: 14 02 2021
accepted: 18 04 2021
pubmed: 7 5 2021
medline: 14 7 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

Recovery of heart function during support with a durable left ventricular assist device (LVAD) is uncommon. There are few reports of cases that address eliminating the LVAD without the need for a heart transplant. Radical surgical removal of the LVAD may distort the left ventricular cavity and thus affect its function, in addition to the associated risks of the operation. Innovative ways to deactivate the LVAD, relying mainly on vascular plugs implanting in the outflow graft, have been used. Few reports have shown the success of this method. In this case report, we review the story of a young patient with advanced heart failure who underwent LVAD implantation. After six months, there was a dramatic improvement of heart function that enabled successful deactivation of the device.

Identifiants

pubmed: 33955018
doi: 10.1111/jocs.15609
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

2974-2978

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Birks EJ , Tansley PD , Hardy J , et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006; 2 355(18):1873-1884. https://doi.org/10.1056/NEJMoa053063
Miller LW , Pagani FD , Russell SD , et al, HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007; 30 357(9):885-896. https://doi.org/10.1056/NEJMoa067758
Slaughter MS , Rogers JG , Milano CA , et al, HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009; 361(23):2241-2251. https://doi.org/10.1056/NEJMoa0909938. Erratum in: N Engl J Med. 2018 Aug 16;379(7):697.
Dandel M , Weng Y , Siniawski H , et al. Pre-explant stability of unloading-promoted cardiac improvement predicts outcome after weaning from ventricular assist devices. Circulation. 2012; 126(11 Suppl 1):S9-S19. https://doi.org/10.1161/CIRCULATIONAHA.111.084640
Cohn WE , Gregoric ID , Radovancevic B , Frazier OH . A felt plug simplifies left ventricular assist device removal after successful bridge to recovery. J Heart Lung Transplant. 2007; 26(11):1209-1211. https://doi.org/10.1016/j.healun.2007.07.029
Hanke JS , Dogan G , Haverich A , Schmitto JD . First-in-man explantation of a HeartMate 3 left ventricular assist device via customized plug. Eur J Cardiothorac Surg. 2020; 57(3):604-606. https://doi.org/10.1093/ejcts/ezz248
Mulzer J , Faerber G , Kaufmann F , Potapov EV . Recovery plug for HeartMate 3 left ventricular assist device. J Thorac Cardiovasc Surg. 2019; 157(2):e35-e37. https://doi.org/10.1016/j.jtcvs.2018.07.041
Gonzalez-Stawinski GV , Mountis MM , Cohn WE , Frazier OH . Inflow graft interruption as a simple method for left ventricular assist device removal after successful bridge to recovery. J Card Surg. 2012; 27(3):397-399. https://doi.org/10.1111/j.1540-8191.2012.01447.x
Pettit SJ , Shapiro LM , Lewis C , Parameshwar JK , Tsui SS . Percutaneous withdrawal of HeartWare HVAD left ventricular assist device support. J Heart Lung Transplant. 2015;34(7):990-992. https://doi.org/10.1016/j.healun.2015.02.002
Zeigler SM , Sheikh AY , Lee PH , et al. A novel, catheter-based approach to left ventricular assist device deactivation after myocardial recovery. Ann Thorac Surg. 2014;98(2):710-713. https://doi.org/10.1016/j.athoracsur.2013.09.073
Pendyal A , Chien CV , Mudd JO , Gelow JM . Minimally invasive LVAD deactivation in a 65-year-old man with recurrent pump thrombosis and left ventricular recovery. Tex Heart Inst J. 2017;44(1):70-72. https://doi.org/10.14503/THIJ-16-5787

Auteurs

Hani N Alkattan (HN)

Department of Cardiac Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Ulf Kjellman (U)

Department of Cardiac Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Nedim Selimovic (N)

Department of Cardiac Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Ahmed Alomrani (A)

Department of Cardiac Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Abdullah A Alghamdi (AA)

Department of Cardiac Sciences, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH